MARKET WIRE NEWS

bioAffinity Technologies Inc. (NASDAQ : BIAF) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company is involved in developing technologies that, in the future, will be able to detect and monitor diseases of the lung and other cancers and treat many cancers.


Quote


Last:$0.7771
Change Percent: -5.75%
Open:$0.806
Close:$0.7771
High:$0.806
Low:$0.733
Volume:1,020,704
Last Trade Date Time:07/08/2026 03:43:06 pm

Stock Data


Market Cap:$4,543,696
Float:4,349,802
Insiders Ownership:N/A
Institutions:3
Short Percent:N/A
Industry:Medical Diagnostics & Screening
Sector:Healthcare
Website:https://www.bioaffinitytech.com
Country:US
City:San Antonio

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


investorshub : US Market News
investorshub : Paulness
investorshub : Paulness
investorshub : Paulness

**MWN-AI FAQ is based on asking OpenAI questions about bioAffinity Technologies Inc. (NASDAQ: BIAF).

Link Market Wire News to Your X Account

Download The Market Wire News App